Acute alcohol‐associated hepatitis: Latest findings in non‐invasive biomarkers and treatment
Authors:
- 15 May 2023
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 45 (3) , e15608
Abstract
Acute alcohol‐associated hepatitis (AH) is a syndrome that occurs in heavy and long‐term drinkers and results in severe jaundice and liver failure. The mortality rate in severe cases is 20%–50% at 28 days, and in cases that do not improve despite appropriately timed corticosteroid therapy, the mortality rate reaches 70% at 6 months. The only curative treatment is early liver transplantation, but less than 2% of patients with severe AH are eligible. In order to improve the prognosis, diagnostic tools are needed to detect appropriate cases at risk of severe conditions, and new therapies need to be developed that can replace corticosteroids. Recent research has revealed that the pathogenesis of AH involves a complex of factors, including changes in the gut microbiota, inflammatory and cytokine signalling, oxidative stress and mitochondrial dysfunction, and abnormalities in the hepatic regenerative capacity. Non‐invasive diagnostic tools focusing on these specific pathologies have been reported in recent years. In addition, several novel agents targeting specific pathways are currently being developed and tested in clinical trials. This review will provide an overview of alcohol‐associated hepatitis and focus on the latest diagnostic tools, particularly non‐invasive biomarkers, and novel therapies.Keywords
Funding Information
- Biomedical Laboratory Research and Development, VA Office of Research and Development (BX004594)
- National Institutes of Health (P30 DK120515)
- National Institutes of Health (P50 AA011999)
- National Institutes of Health (R01 AA24726)
- National Institutes of Health (R37 AA020703)
- National Institutes of Health (U01 AA026939)
- National Institutes of Health (U01 AA026939‐04S1)
- Harrington Discovery Institute, University Hospitals (Harrington Scholar‐Innovator Award)
This publication has 115 references indexed in Scilit:
- Tax Policy, Adult Binge Drinking, and Youth Alcohol Consumption in the United StatesAlcohol, Clinical and Experimental Research, 2013
- MicroRNA Signature in Alcoholic Liver DiseaseInternational Journal of Hepatology, 2012
- Alcohol Brand Preferences of Underage Youth: Results from a Pilot Survey among a National SampleSubstance Abuse, 2011
- Alcoholic Beverage Preferences and Associated Drinking Patterns and Risk Behaviors Among High School YouthAmerican Journal of Preventive Medicine, 2011
- Ethanol-Induced Expression of ET-1 and ET-BR in Liver Sinusoidal Endothelial Cells and Human Endothelial Cells Involves Hypoxia-Inducible Factor-1α and MicroRNA-199The Journal of Immunology, 2009
- Toward unraveling the complexity of simple epithelial keratins in human diseaseJournal of Clinical Investigation, 2009
- Granulocyte‐colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitisHepatology, 2008
- Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroidsJournal of Hepatology, 2008
- The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroidsGut, 2007
- Prevalence of Septic Events, Type 1 Hepatorenal Syndrome, and Mortality in Severe Alcoholic Hepatitis and Utility of Discriminant Function and MELD Score in Predicting These Adverse EventsDigestive Diseases and Sciences, 2006